Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Drug Manufacturers - Major


Interviews

Canada’s top edible cannabis producer eyes further growth

Medicus Pharma advances cancer treatment towards phase II trial

Emerging opportunity in a growing, high-value dermatological market

Pharmaceutical company treats bladder cancer with new tech

Press Releases

WELL Health Technologies Announces Collaboration with Microsoft to Accelerate Healthcare's...

  Apr 30, 2024

CloudMD Announces Late Filing of Annual Financial Statements

  Apr 29, 2024

Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2...

  Apr 30, 2024

BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU...

  Apr 30, 2024

Goodness Growth Holdings to Release First Quarter 2024 Results on May 7, 2024

  Apr 30, 2024

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

  Apr 30, 2024

Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance...

  Apr 30, 2024

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur(TM)

  Apr 30, 2024

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth...

  Apr 30, 2024

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update...

  Apr 30, 2024

Grown Rogue Completes Fiscal Year End Change, Reports Audited Financial Results for the Two...

  Apr 30, 2024

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortiso...

  Apr 30, 2024

AirSculpt Technologies Announces First Quarter 2024 Earnings Release Date and Conference Call

  Apr 30, 2024

Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to...

  Apr 30, 2024

PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating...

  Apr 30, 2024

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of...

  Apr 30, 2024

Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

  Apr 30, 2024

Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of...

  Apr 30, 2024

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary...

  Apr 30, 2024

BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global...

  Apr 30, 2024

Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position

  Apr 30, 2024

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8,...

  Apr 30, 2024

MiNK to Provide Corporate Update and First Quarter 2024 Financial Report

  Apr 30, 2024

Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024...

  Apr 30, 2024

STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024

  Apr 30, 2024

IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma

  Apr 30, 2024

Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Ga...

  Apr 30, 2024

MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases

  Apr 30, 2024

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

  Apr 30, 2024

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers

  Apr 30, 2024

ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authoriz...

  Apr 30, 2024

Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus...

  Apr 30, 2024

Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024

  Apr 30, 2024

OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry...

  Apr 30, 2024

ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis...

  Apr 30, 2024

Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities...

  Apr 30, 2024

Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities...

  Apr 30, 2024

Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA...

  Apr 30, 2024

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under...

  Apr 30, 2024

Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry...

  Apr 30, 2024

ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Bet...

  Apr 30, 2024

Neogen® Launches New Molecular Method for Detection of Two Salmonella Serotypes

  Apr 30, 2024

Teleflex Announces the Limited Market Release of the Wattson(TM) Temporary Pacing Guidewire

  Apr 30, 2024

Appendix 4C - Q3 FY24 Quarterly Cash Flow Report

  Apr 30, 2024

Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Recepto...

  Apr 30, 2024

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and...

  Apr 30, 2024

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued...

  Apr 30, 2024

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device...

  Apr 30, 2024

Alignment Healthcare to Present at Two Investor Conferences in May 2024

  Apr 30, 2024

Truvaga(TM) Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for...

  Apr 30, 2024

More

Agriculture Building Materials Cannabis Chemicals Coal Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Forest Products Healthcare Industrials Metals & Mining Gold Industrial Metals & Minerals Silver Real Estate Steel Technology Utilities